PCP Care in Hospital Linked to Resource Use, Outcome

Share this content:
PCP Care in Hospital Linked to Resource Use, Outcome
PCP Care in Hospital Linked to Resource Use, Outcome

WEDNESDAY, Nov. 15, 2017 (HealthDay News) -- Patients cared for in the hospital by their own primary care physician (PCP) have longer length of stay and are more likely to be discharged home than those cared for by hospitalists or other generalists, according to a study published online Nov. 13 in JAMA Internal Medicine.

Jennifer P. Stevens, M.D., from Beth Israel Deaconess Medical Center in Boston, and colleagues performed a retrospective study to examine differences in health care resource use and outcomes among hospitalized patients cared for by hospitalists, their own PCP, or other generalists. Data were obtained from Medicare Parts A and B claims data for 560,651 admissions.

The researchers found that patients cared for by PCPs and other generalists versus hospitalists had lengths of stay that were 12 and 6 percent longer, respectively. PCPs were more likely and other generalists were less likely to discharge patients home (adjusted odds ratios [AORs], 1.14 and 0.94, respectively). Patients cared for by PCPs had similar readmission rates at seven days and 30 days relative to patients cared for by hospitalists; readmission rates were greater for generalists at seven and 30 days. Thirty-day mortality was lower for patients cared for by PCPs than hospitalists (AOR, 0.94), while the mortality rate was higher for those cared for by other generalists (AOR, 1.09).

"A PCP's prior experience with a patient may be associated with inpatient use of resources and patient outcomes," the authors write.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »